Intercept Pharmaceuticals, Inc. logo

Intercept Pharmaceuticals, Inc. Share Price (NASDAQ: ICPT)

▲

-19

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 7 Nov 2023

Check the interactive Intercept Pharmaceuticals, Inc. Stock chart to analyse performance

Intercept Pharmaceuticals, Inc. Key Stats

Check Intercept Pharmaceuticals, Inc. key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$19.0
Open
$19.0
Market Capitalization
$793.5M
Today's Volume
$4.0M
Revenue TTM
$306.5M
EBITDA
$-66.5M
Earnings Per Share (EPS)
$-4.26
Dividend Yield
0.0%
Profit Margin
68.07%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

Global Institutional Holdings in Intercept Pharmaceuticals, Inc.

  • Name

    Holdings %

  • Vanguard Group Inc

    11.23%

  • BlackRock Inc

    10.52%

  • State Street Corporation

    10.00%

  • Deerfield Management Co

    4.97%

  • UBS Group AG

    3.25%

  • Caligan Partners LP

    3.09%

Analyst Recommendation on Intercept Pharmaceuticals, Inc. Stock

Rating
Trend

Hold

    35%Buy

    65%Hold

    0%Sell

Based on 20 Wall street analysts offering stock ratings for Intercept Pharmaceuticals, Inc.(by analysts ranked 0 to 5 stars)

About Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in adults. It is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis and NASH; and other product candidates in various stages of clinical and preclinical development. The company has a license agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. It markets its products through an internal commercial organization and third-party distributors. The company was incorporated in 2002 and is headquartered in Morristown, New Jersey.
Organization
Intercept Pharmaceuticals, Inc.
Employees
341
CEO
Mr. Jerome B. Durso
Industry
Health Technology

Important FAQs about investing in ICPT Stock from India :

What is Intercept Pharmaceuticals, Inc. share price today?

Intercept Pharmaceuticals, Inc. share price today is as on at the close of the market. Intercept Pharmaceuticals, Inc. share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Intercept Pharmaceuticals, Inc. share?

Intercept Pharmaceuticals, Inc. share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Intercept Pharmaceuticals, Inc. stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Intercept Pharmaceuticals, Inc. Stock (ICPT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Intercept Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Intercept Pharmaceuticals, Inc. Shares .

What is the minimum amount required to buy Intercept Pharmaceuticals, Inc. Stock (ICPT) from India?

Indian investors can start investing in Intercept Pharmaceuticals, Inc. (ICPT) shares with as little as ₹89.35 or $1 (as of November 22, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹893.50 in Intercept Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on November 22, 2025). Learn more about fractional shares .

What are the returns that Intercept Pharmaceuticals, Inc. has given to Indian investors in the last 5 years?

Intercept Pharmaceuticals, Inc. stock has given 0.0% share price returns and 20.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?